Company newsMRNA
Explain this story: Establishment Labs presents clinical data, expands product lines
Establishment Labs Holdings Inc. (NASDAQ:ESTA) announced the presentation of clinical and scientific data for its Breast Tissue Preservation technology and Minimally Invasive Platform at the 11th World Symposium on Ergonomic Implants. The company also introduced product line extensions for its Mia and Preservé products, including new sizes and supporting tools. This expansion aligns with the growth in the breast augmentation market and solidifies the foundation for future advancements in the field.
OtherInvesting.comSector and industry: HealthcareBiotechnologyTell me moreShow less
We have not explained this story yet. The original headline, summary and link are below.
Establishment Labs Holdings Inc. (NASDAQ:ESTA) announced the presentation of clinical and scientific data for its Breast Tissue Preservation technology and Minimally Invasive Platform at the 11th World Symposium on Ergonomic Implants. The company also introduced product line extensions for its Mia and Preservé products, including new sizes and supporting tools. This expansion aligns with the growth in the breast augmentation market and solidifies the foundation for future advancements in the field.
Article tone: Neutral This describes the words the journalist used. It is not a prediction, and not advice.
Also mentioned:MRNA
Published Sep 22, 2026, 04:12 ET · on this site +4d 21h